Thiamine is important not only in the metabolism of acetylcholine but also in its release from the presynaptic neuron. Pathologic, clinical, and biochemical data suggest that thiamine deficiency is detrimental to the cholinergic system and that thiamine-dependent enzymes may be altered in Alzheimer's disease. Two previous studies reported contradictory results in patients with dementia of Alzheimer's type treated with 3 g/day of thiamine. In the present study, we examined the effects of 3 to 8 g/day thiamine administered orally. Our results suggest that thiamine at these pharmacologic dosages may have a mild beneficial effect in dementia of Alzheimer's type. The mechanism of the observed effect is unknown, but the findings warrant further investigation, not only for their therapeutic implications but for their possible etiologic clues. In addition, the results suggest long-term carry-over effects that should be considered in the design of future studies.
Get full access to this article
View all access options for this article.
References
1.
1. Blass JP, Gleason P, Brush D, et al: Thiamine and Alzheimer's disease. Arch Neurol1988; 45:833–835.
2.
2. Gibson G, Barclay L, Blass JP: The role of the cholinergic system in thiamin deficiency. Ann N Y Acad Sci1982; 378:382–403.
3.
3. Iwata H, Inoue A, Tomoi M: Enhancement of brain thiamine diphosphatase activity of rats by injection of cholinergic drugs. J Neurochem1971; 18:1371–1377.
4.
4. Eder L, Hirt L, Dunant Y: Possible involvement of thiamine in acetylcholine release. Nature1976; 264:186–188.
5.
5. Eder L, Dunant Y: Thiamine and cholinergic transmission in the electric organ of torpedo. J Neurochem1980; 35:1278–1296.
6.
6. Gehlert DR, Morey WA, Wamsley JK: Alterations in muscarinic cholinergic receptor densities induced by thiamine deficiency: Autoradiographic detection of changes in high- and low-affinity agonist binding. J Neurosci Res1985; 13:443–452.
7.
7. Barclay LL, Gibson GE, Blass JP: Impairment of behavior and acetylcholine metabolism in thiamine deficiency. J Pharmacol Exp Ther1981; 217:537–543.
8.
8. Barclay LL, Gibson GE, Blass JP: Cholinergic therapy of abnormal open-field behavior in thiamin-deficient rats. J Nutr1982; 112:1906–1913.
9.
9. Kulkarni AB, Gaitonde BB: Effects of early thiamine deficiency and subsequent rehabilitation on the cholinergic system in developing rat brain. J Nutr Sci Vitaminol1983; 29:217–225.
10.
10. Micheau J, Durkin TP, Destrade C, et al: Chronic administration of sulbutiamine improves long term memory formation in mice: Possible cholinergic mediation. Pharmacol Biochem Behav1985; 23:195–198.
11.
11. Gibson GE, Sheu KFR, Blass JP, et al: Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol1988; 45:836–840.
12.
12. Sheu KFR, Clarke DD, Kim YT, et al: Studies of transketolase abnormality in Alzheimer's disease. Arch Neurol1988; 45:841–845.
13.
13. Butterworth RF, Besnard AM: Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease. Metab Brain Dis1990; 5:179–184.
14.
14. Héroux M, Besnard AM, Butterworth RF: Evidence for altered thiamine neurochemistry in Alzheimer's disease. Soc Neurosci Abstr1991; 1:726.
15.
15. Whitehouse PJ, Price DL, Struble RG, et al: Alzheimer's disease and senile dementia: Loss of neurons in the basal fore-brain. Science1982; 215:1237–1239.
16.
16. Arendt T, Bigl V, Tennstedt A: Loss of neurones in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans, and Korsakoff's disease. Acta Neuropathol1983; 61:101–108.
17.
17. Squire LR, Butters N (eds): Neuropsychology of Memory. New York, Guilford Press, 1984.
18.
18. Nolan KA, Black RS, Sheu KFR, et al: A trial of thiamine in Alzheimer's disease. Arch Neurol1991; 48:81–83.
19.
19. Rosen WG, Mohs RC, Davis KL: A new rating scale for Alzheimer's disease. Am J Psychiatr1984; 141:1356–1364.
21. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology. Bethesda, MD, Department of Health, Education, and Welfare, Publication, No. 76–338 (ADM). 1976, pp 218–222.
22.
22. DiPalma JR, Hitchcock P: Neuromuscular and ganglionic blocking action of thiamine and its derivatives. Anesthesiology1958; 19:762–769.
26. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease. Neurology1984; 34:939–944.
27.
27. Hachinski VC, Lassen NA, Marshall J: Multi-infarct dementia: A cause of mental deterioration in the elderly. Lancet1974; 2:207–210.
28.
28. Haas RH: Thiamine and the brain. Annu Rev Nutr1988; 8:483–515.
29.
29. Butterworth RF, Héroux M: Effect of pyrithiamine treatment and subsequent thiamine rehabilitation on regional cerebral amino acids and thiamine-dependent enzymes. J Neurochem1989; 52:1078–1084.
30.
30. Arendt T, Schugens MM, Marchbanks RM: Reversible inhibition of acetylcholine synthesis and behavioral effects caused by 3-bromopyruvate. J Neurochem1990; 55:1474–1479.
31.
31. Doerge DR, McNamee MG, Ingraham LL: Some neurochemical properties of thiamine, in Sable HZ, Gubler CJ (eds): Thiamine: Twenty years of progress. Ann NY Acad Sci1978; 378:422–433.
32.
32. Doerge DR, McNamee MG, Ingraham LL: Modification of acetylcholine receptor-mediated ion permeability by thiamine. Mol Pharmacol1979; 15:747–750.
33.
33. Cooper JR, Pincus JH: The role of thiamine in nervous tissue. Neurochem Res1979; 4:223–239.
34.
34. Salmon DP, Thai LJ, Butters N, Heindel WC: Longitudinal evaluation of dementia of Alzheimer type: A comparison of 3 standardized mental status examinations. Neurology1990; 40:1225–1230.
35.
35. Scileppi KP, Blass JP, Baker HG: Circulating vitamins in Alzheimer's dementia as compared to other dementias. J Am Geriatr Soc1984; 32:709–711.
36.
36. Schaumburg H, Kaplan J, Windebank A, et al: Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med1983; 309:445–448.
37.
37. Mills CA: Thiamine overdosage and toxicity. JAMA1941; 116:2101–2102.
38.
38. Franke P, Meador KJ, Loring DW, et al: Effects of high dose thiamine on scopolamine-induced cognitive deficits, abstract. J Clin Exp Neuropsychol1992; 14:60.
39.
39. Freeman GB, Nielson PE, Gibson GE: Effect of age on behavioral and enzymatic changes during thiamine deficiency. Neurobiol Aging1987; 8:429–434.
40.
40. Pincus JH, Cooper JR, Murphy JV, et al: Thiamine derivatives in subacute necrotizing, encephalomyelopathy. Pediatrics1973; 51:716–721.
